ClinicalTrials.Veeva

Menu

Short-term Outcomes of Transanal Total Mesorectal Excision With Structured Training Curriculums in China

S

Shanghai Minimally Invasive Surgery Center

Status

Completed

Conditions

Rectal Cancer

Treatments

Other: Procedure/Surgery

Study type

Observational

Funder types

Other

Identifiers

NCT05108753
MISC-TaTME-RETRO

Details and patient eligibility

About

Transanal total mesorectal excision (TaTME) is an alternative for mid-low rectal cancer. In China, this procedure has been performed in high-volume centers with structured training curriculums. This study aimed to evaluate the short-term outcomes during the initial implementation of the TaTME procedure in high-volume centers who followed structured training curriculums in China.

Enrollment

175 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 18 and 75 years
  • American Society of Anesthesiologists (ASA) score I to III
  • A biopsy proven histological diagnosis of rectal carcinoma
  • Undergoing transanal total mesorectal excision

Exclusion criteria

  • Pregnant or lactating women
  • Synchronous rectal carcinoma
  • History of colorectal cancer or other malignant tumors
  • Clinical evidence of metastasis
  • Emergency procedure

Trial design

175 participants in 3 patient groups

Group 1
Description:
5 patients underwent TaTME under proctoring
Treatment:
Other: Procedure/Surgery
Group 2
Description:
the first 10 patients underwent TaTME without proctoring
Treatment:
Other: Procedure/Surgery
Group 3
Description:
the second 10 patients underwent TaTME without proctoring
Treatment:
Other: Procedure/Surgery

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems